CRIS Current Research Information System

CASADEI, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 21.481
NA - Nord America 20.835
EU - Europa 20.252
AF - Africa 1.396
SA - Sud America 1.268
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 65.272
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.566
IT - Italia 6.532
SG - Singapore 5.639
CN - Cina 5.626
VN - Vietnam 5.592
GB - Regno Unito 3.916
DE - Germania 2.157
SE - Svezia 1.873
HK - Hong Kong 1.631
FR - Francia 1.147
IN - India 1.063
UA - Ucraina 972
BR - Brasile 925
RU - Federazione Russa 824
IE - Irlanda 602
NL - Olanda 467
CH - Svizzera 440
JP - Giappone 433
FI - Finlandia 375
KR - Corea 367
ZA - Sudafrica 350
TG - Togo 300
EE - Estonia 285
CI - Costa d'Avorio 254
SC - Seychelles 199
AT - Austria 157
AR - Argentina 152
CA - Canada 152
NG - Nigeria 149
PH - Filippine 138
JO - Giordania 112
BD - Bangladesh 108
TH - Thailandia 102
ID - Indonesia 91
TR - Turchia 90
BG - Bulgaria 88
MX - Messico 85
IQ - Iraq 82
PL - Polonia 79
BE - Belgio 77
EC - Ecuador 61
TW - Taiwan 57
IR - Iran 55
PK - Pakistan 45
GR - Grecia 44
ES - Italia 43
SA - Arabia Saudita 39
CL - Cile 32
LB - Libano 32
CO - Colombia 31
MA - Marocco 31
UZ - Uzbekistan 31
MY - Malesia 30
AU - Australia 24
LT - Lituania 23
AE - Emirati Arabi Uniti 22
NP - Nepal 20
PY - Paraguay 19
RO - Romania 19
CZ - Repubblica Ceca 18
EG - Egitto 18
TN - Tunisia 18
ET - Etiopia 16
DZ - Algeria 15
PT - Portogallo 15
KE - Kenya 14
PE - Perù 14
VE - Venezuela 14
RS - Serbia 11
SK - Slovacchia (Repubblica Slovacca) 11
AL - Albania 10
DK - Danimarca 10
HR - Croazia 10
KZ - Kazakistan 10
OM - Oman 10
BO - Bolivia 9
UY - Uruguay 8
DO - Repubblica Dominicana 7
EU - Europa 6
IL - Israele 6
MD - Moldavia 6
PA - Panama 6
BY - Bielorussia 5
CR - Costa Rica 5
CY - Cipro 5
KG - Kirghizistan 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
SI - Slovenia 5
AZ - Azerbaigian 4
HU - Ungheria 4
JM - Giamaica 4
MU - Mauritius 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
KW - Kuwait 3
Totale 65.195
Salva come PNG Salva come JPEG
Città #
Singapore 3.797
Southend 3.464
Ashburn 2.274
Fairfield 1.750
Chandler 1.649
Hong Kong 1.513
Ho Chi Minh City 1.196
San Jose 1.038
Hanoi 1.008
Santa Clara 961
Dong Ket 849
Hefei 796
Princeton 782
Beijing 745
Wilmington 718
Jacksonville 638
Dublin 600
Woodbridge 591
Houston 590
Milan 577
Seattle 575
Bologna 523
Ann Arbor 482
Los Angeles 469
Boardman 448
Cambridge 446
Rome 439
Lauterbourg 438
New York 402
Bern 384
Tokyo 373
Dallas 342
Padova 324
Nanjing 318
Westminster 317
Helsinki 313
Lomé 300
Seoul 298
Abidjan 254
Berlin 239
Florence 217
Medford 193
Turin 190
Da Nang 181
Haiphong 171
Shenyang 171
Buffalo 168
Jinan 160
Frankfurt am Main 159
Saint Petersburg 156
Redondo Beach 145
Abeokuta 136
Guangzhou 129
Shanghai 129
Munich 127
Tianjin 124
Council Bluffs 121
Hebei 120
Naples 119
Mülheim 117
Bremen 114
Changsha 112
Nanchang 111
Amman 110
Redmond 105
Vienna 103
San Diego 99
São Paulo 97
Dearborn 95
Sofia 82
Verona 82
Des Moines 79
Bengaluru 77
Falkenstein 77
Hangzhou 76
Redwood City 74
Mahé 73
Johannesburg 72
Nuremberg 71
Zhengzhou 69
Yubileyny 65
Jiaxing 64
Brussels 62
Phoenix 62
Bari 61
Biên Hòa 60
Genoa 59
Chicago 58
Hải Dương 58
Orem 58
The Dalles 57
Amsterdam 56
Norwalk 56
Olalla 56
Can Tho 55
London 54
Palermo 52
Catania 50
Wuhan 49
Montreal 48
Totale 39.171
Salva come PNG Salva come JPEG
Nome #
EMORRAGIA DA PROCTITE ATTINICA: EMOSTASI E TRATTAMENTO 4.224
Linfagioma cistico del surrene 380
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 340
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 337
Radiomic analysis performed on 68Ga-DOTANOC PET/CT allows discriminating primary pancreatic neuroendocrine tumour grading 297
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 268
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 267
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: a single center prospective, randomized controlled study. 257
A [68Ga]Ga-DOTANOC PET/CT radiomic model for non-invasive prediction of tumour grade in pancreatic neuroendocrine tumours 256
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer 255
Higher number of known pancreatic cancer mutations highlighted by whole-transcripto- me and whole-exome sequencing predicts cli- nical outcome in early stage patients 253
Adjuvant chemoradiation in pancreatic cancer: Impact of radiotherapy dose on survival 245
Esplorazione chirurgica. 239
A study of the relationship between idiopathic hyperenzymemia and dyslipidemia. 238
Are the New IPMN’s Guideline Effective to Predict the Presence of Invasive IPM Carcinoma? A Single Center Experience. 238
Air in the Wirsung duct. An unusual finding. 235
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 235
La chirurgia nell’adenocarcinoma gastrico resecabile: evidenze a confronto. 235
β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer 235
Comparing PET-derived semiquantitative parameters and radiomic features in discriminating G1 and G2 primary pancreatic neuroendocrine tumours in 68Ga-DOTANOC PET/CT 234
A critical and comprehensive systematic review and meta-analysis of studies comparing intracorporeal and extracorporeal anastomosis in laparoscopic right hemicolectomy 233
Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report 230
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 229
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer 223
Comparison of Blumgart Anastomosis with Duct-to-Mucosa Anastomosis and Invagination Pancreaticojejunostomy After Pancreaticoduodenectomy: A Single-Center Propensity Score Matching Analysis 223
A Rare Case of Borderline Resectable Carcinosarcoma. 222
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 220
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 220
PANCREATIC METASTASES: OBSERVATIONS OF THREE CASES AND REVIEW OF THE LITERATURE 219
Contrast-enhanced ultrasound in the differential diagnosis of exocrine versus neuroendocrine pancreatic tumors 218
Endocrine pancreatic tumors: factors correlated with survival. 216
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases 215
Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre 213
Minimally Invasive Pancreaticoduodenectomy: What is the Best “Choice”? A Systematic Review and Network Meta-analysis of Non-randomized Comparative Studies 213
Intraductal papillary mucinous neoplasms: the bologna experience. Lessons learned from 357 cases observed in a tertiary care center 211
Advanced laparoscopic surgery: comparison cost-reimbursement. 211
DRG chirurgici: rapporto costo/rimborso nella colecistectomia laparoscopica. 210
Pancreasectomia centrale o intermedia: indicazioni e note di tecnica 210
Il trattamento del moncone pancreatico dopo duodenocefalopancreasectomia: pancreatico-digiunostomia su ansa esclusa 209
WHO 2010 classification of pancreatic endocrine tumors. Is the new always better than the old? 209
TERC and c-MYC COPY number gain in intraductal papillary mucinous neoplasms (IPMNs): promising biomarkers of progression to malignancy 209
IL trattamento chirurgico dei tumori neuroendocrini pancreatico-duodenali nei pazienti con MEN 1. 208
Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience 208
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 208
Clinical outcome of patients who underwent total pancreatectomy. 207
Impact of surgery and surveillance in the management of branch duct intraductal papillary mucinous neoplasms of the pancreas according to Fukuoka guidelines: the Bologna experience 202
A study of the relationship between idiopathic pancreatic hyperenzynemia and dyslipidemia 201
Intraductal Papillary Mucinous Neoplasms: The Bologna Experience 200
A bizarre foreign body of the appendix: a case report. 199
Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression 197
Multicolour versus monocolour inking specimens after pancreaticoduodenectomy for periampullary cancer: A single centre prospective randomised clinical trial 197
Pancreatic metastasis from renal cell carcinoma 196
Are There Prognostic Factors Related to Recurrence in Pancreatic Endocrine tumors? 196
Gli Strumenti dell’ EBM: Utilizzo del Nomogramma di Fagan in una diagnosi difficile 193
Carcinomi surrenalici: analisi di una casistica di 20 casi osservati presso la I Clinica Chirurgica dell’Università di Bologna. 191
Comparison of Efficacy and Safety of 4 Combinations of Laparoscopic and Intraoperative Techniques for Management of Gallstone Disease With Biliary Duct Calculi: A Systematic Review and Network Meta-analysis 191
Autoimmune Pancreatitis Associated with Anisakis Infection 190
TERC AND MYC COPY NUMBER GAIN AS POWERFUL GENETIC MARKERS FOR INTRADUCTAL PAPILLARY NEOPLASMS OF THE PANCREAS 190
Chronic asymptomatic pancreatic hyperenzymemia is a benign condition in only half of the cases: a prospective study 190
Angiodisplasie dell’apparato digerente: esperienza della I Clinica Chirurgica dell’Università di Bologna. 190
Radiomic analysis could allow detecting misassigned bioptic grading when discriminating G1 and G2 primary pancreatic neuroendocrine tumours imaged with 68Ga-DOTANOC PET/CT 190
Converted laparoscopic distal pancreatectomy: is there an impact on patient outcome and total cost? 189
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid 189
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 189
Co-morbidities and pancreatic stump treatment after pancreaticoduodenectomy: are they linked to postoperative morbidity? 188
Magnetic resonance cholangiopancreatography in asymptomatic pancreatic hyperenzymemia 187
Are the tumor size a limit to laparoscopic adrenalectomy? 184
Endocrine tumors of the ileum: factors correlated with survival. 184
Resezioni pancreatiche per cancro in pazienti anziani. 183
GemOx and Ovarian Pancreatic Cancer Metastasis (PC) 183
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 183
Branch duct intraductal papillary mucinous neoplasm: validation of Fukuoka 2012 guidelines using a systematic review and meta-analysis 183
The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours. 183
G1/G2 discrimination of pNET with [68Ga]Ga-DOTANOC PET/CT quantitative parameters: is it feasible? 183
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 182
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 182
Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer 181
A search for acute necrotic pancreatitis in early stages of alcoholic chronic pancreatitis 181
Vacuum Assisted Closure Therapy in Severe Acute Pancreatitis: Case Report and Literature Review. 181
Clinical impact of nonselective beta-blockers on survival in patients with pancreatic cancer- revival of well known drugs? 181
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 180
Searching for novel multimodal treatments in oligometastatic pancreatic cancer 178
Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries 177
State of the art biological therapies in pancreatic cancer 177
Il percorso diagnostico preoperatorio e la preparazione all'intervento chirurgico 175
Comparing RECIST and Choi's Criteria After Neoadjuvant Chemoradiotherapy in Patients with Resectable Pancreatic Cancer 175
Chirurgia pancreatica laparoscopica vs laparotomia: rapporto costi-benefici. Esperienza della I Clinica Chirurgica del S.Orsola-Malpighi. 174
Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis – An international cohort study 174
Prospective validation of a preoperative risk score model based on pancreatic texture to predict postoperative pancreatic fistula after pancreaticoduodenectomy. 172
Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study 172
Pancreatic cyst surveillance imposes low psychological burden 172
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 171
Il percorso diagnostico-terapeutico dei tumori del pancreas nel Policlinico S.Orsola-Malpighi: risultati della chirurgia a 6 mesi dalla sua applicazione. 170
Emorragia da proctite attinica: emostasi e trattamento. 170
Intraductal papillary mucinous neoplasms: the Bologna experience. Lessons learned from 357 cases observed in a tertiary care center 170
Contrast-enhanced endoscopic ultrasound for the differential diagnosis between benign and malignant lymph nodes: a meta-analysis 170
Treatment of advanced gastro‐entero‐pancreatic neuro‐ endocrine tumors: A systematic review and network meta‐analysis of phase iii randomized controlled trials 170
Risk Factors in Resected Pancreatic Cancer. A Single Centre Experience 169
Are There Predicting Factors Related to a “Soft Pancreas”? 169
Autoimmune pancreatitis associated with anisakis infection 168
Totale 24.724
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.192
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.350 0 0 0 0 0 0 0 0 0 345 339 1.666
2021/20227.599 508 324 306 630 594 391 145 539 315 469 2.173 1.205
2022/20238.666 749 1.240 446 990 629 660 267 480 1.351 371 828 655
2023/20243.068 230 401 222 229 236 567 223 227 117 192 207 217
2024/20259.961 456 1.401 869 629 1.564 609 817 420 220 648 457 1.871
2025/202621.770 1.789 2.082 2.025 1.634 2.378 1.337 2.973 1.136 4.589 1.827 0 0
Totale 66.487